Express Scripts Holding Company (ESRX) Shares Sold by Callahan Advisors LLC

Callahan Advisors LLC decreased its position in shares of Express Scripts Holding Company (NASDAQ:ESRX) by 28.2% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 17,555 shares of the company’s stock after selling 6,902 shares during the quarter. Callahan Advisors LLC’s holdings in Express Scripts Holding were worth $1,112,000 as of its most recent filing with the Securities & Exchange Commission.

Several other large investors have also recently bought and sold shares of the company. Dodge & Cox boosted its holdings in Express Scripts Holding by 25.7% in the second quarter. Dodge & Cox now owns 36,188,517 shares of the company’s stock worth $2,310,275,000 after purchasing an additional 7,388,021 shares during the last quarter. Pzena Investment Management LLC purchased a new stake in Express Scripts Holding in the second quarter worth approximately $181,234,000. Renaissance Technologies LLC boosted its holdings in Express Scripts Holding by 9,353.3% in the first quarter. Renaissance Technologies LLC now owns 1,308,239 shares of the company’s stock worth $86,226,000 after purchasing an additional 1,294,400 shares during the last quarter. Baupost Group LLC MA purchased a new stake in Express Scripts Holding in the first quarter worth approximately $80,978,000. Finally, Northern Trust Corp boosted its holdings in Express Scripts Holding by 12.2% in the second quarter. Northern Trust Corp now owns 11,068,777 shares of the company’s stock worth $706,629,000 after purchasing an additional 1,206,980 shares during the last quarter. Hedge funds and other institutional investors own 89.44% of the company’s stock.

Several research analysts have weighed in on ESRX shares. Jefferies Group LLC reiterated a “buy” rating on shares of Express Scripts Holding in a research report on Thursday, October 26th. Royal Bank Of Canada set a $66.00 price target on shares of Express Scripts Holding and gave the stock a “hold” rating in a research report on Wednesday, October 25th. Robert W. Baird increased their price target on shares of Express Scripts Holding from $57.00 to $59.00 and gave the stock a “neutral” rating in a research report on Wednesday, October 25th. Mizuho set a $67.00 price objective on shares of Express Scripts Holding and gave the company a “hold” rating in a research report on Tuesday, October 24th. Finally, Zacks Investment Research downgraded shares of Express Scripts Holding from a “buy” rating to a “sell” rating in a research report on Tuesday, October 24th. Seven analysts have rated the stock with a sell rating, ten have assigned a hold rating, six have given a buy rating and one has issued a strong buy rating to the company. The stock has a consensus rating of “Hold” and a consensus price target of $69.53.

In related news, CEO Timothy C. Wentworth acquired 8,000 shares of the stock in a transaction on Tuesday, October 31st. The stock was bought at an average cost of $61.13 per share, with a total value of $489,040.00. Following the transaction, the chief executive officer now directly owns 98,628 shares in the company, valued at $6,029,129.64. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, VP Everett Neville sold 1,163 shares of the business’s stock in a transaction dated Wednesday, August 23rd. The shares were sold at an average price of $61.48, for a total transaction of $71,501.24. Following the completion of the sale, the vice president now directly owns 18,232 shares of the company’s stock, valued at $1,120,903.36. The disclosure for this sale can be found here. Over the last three months, insiders sold 6,284 shares of company stock valued at $397,421. 0.68% of the stock is owned by corporate insiders.

COPYRIGHT VIOLATION WARNING: “Express Scripts Holding Company (ESRX) Shares Sold by Callahan Advisors LLC” was originally reported by Week Herald and is owned by of Week Herald. If you are reading this report on another domain, it was stolen and republished in violation of U.S. and international copyright & trademark law. The original version of this report can be accessed at https://weekherald.com/2017/11/15/express-scripts-holding-company-esrx-shares-sold-by-callahan-advisors-llc.html.

Express Scripts Holding Company (ESRX) opened at $60.25 on Wednesday. Express Scripts Holding Company has a 52 week low of $55.80 and a 52 week high of $77.50. The company has a current ratio of 0.73, a quick ratio of 0.61 and a debt-to-equity ratio of 0.86. The company has a market cap of $34,480.00, a PE ratio of 8.78, a P/E/G ratio of 0.89 and a beta of 0.88.

Express Scripts Holding (NASDAQ:ESRX) last released its quarterly earnings data on Tuesday, October 24th. The company reported $1.90 earnings per share (EPS) for the quarter, meeting the consensus estimate of $1.90. The company had revenue of $24.68 billion during the quarter, compared to analysts’ expectations of $25.68 billion. Express Scripts Holding had a net margin of 3.64% and a return on equity of 25.46%. The firm’s quarterly revenue was down 2.9% on a year-over-year basis. During the same period in the previous year, the company earned $1.74 EPS. analysts predict that Express Scripts Holding Company will post 7.01 earnings per share for the current year.

About Express Scripts Holding

Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).

Institutional Ownership by Quarter for Express Scripts Holding (NASDAQ:ESRX)

Receive News & Ratings for Express Scripts Holding Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts Holding Company and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply